IP Library › Assignment 017656/0059
Patent Assignment
Reel/Frame 017656/0059

Change of Name

Recorded: 2006-05-19 Pages: 4
Assignor
SYN X PHARMA INC.
Executed: 2006-02-09
Assignee
NANOGEN POINT OF CARE INC.
1 MARMAC DRIVE, TORONTO, ONTARIO, M9W 1E7, CANADA
Covered Property (1)
Inter-Alpha Trypsin Inhibitor Biopolymer Marker Indicative of Insulin Resistance
Patent: 7,015,004 →
Application: 09/993,295 →
Publication: US 2005/0287595
Related Assignments (6)
Other recorded transfers of the patent in this record — the chain of ownership.
Security Agreement Jul 18, 2003
From: SYNX PHARMA INC.
To: CANADA TRUST COMPANY, THE
Reel/Frame 014242/0790 →
Security Interest Feb 12, 2004
From: SYNX PHARMA INC.
To: NANOGEN, INC.
Reel/Frame 014337/0010 →
Assignment of Assignor's Interest May 31, 2006
From: NANOGEN POINT OF CARE INC.
To: NANOGEN INC.
Reel/Frame 017706/0515 →
Assignment of Intellectual Property Security Agreement Apr 15, 2008
From: THE CANADA TRUST COMPANY
To: NANOGEN, INC.
Reel/Frame 020807/0247 →
Release of Security Interest Apr 17, 2008
From: NANOGEN POINT OF CARE, INC.
To: NANOGEN, INC.
Reel/Frame 020826/0087 →
Grant of Security Interest Jul 25, 2008
From: NANOGEN, INC.
To: PORTSIDE GROWTH & OPPORTUNITY FUND, AS COLLATERAL AGENT
Reel/Frame 021291/0605 →